MedPath

Split or Whole Liver Transplantation? A Multicenter Retrospective Cohort Study of Patients With Benign and Malignant Liver Disease

Completed
Conditions
Zhejiang University
Registration Number
NCT06359496
Lead Sponsor
Zhejiang University
Brief Summary

The primary objective of this study was to assess the safety and feasibility of split liver transplantation(SLT) for adult hepatocellular carcinoma (HCC) patients, while comparing the prognostic disparities between adult SLT and WLT also .

Liver transplantation (LT) is an effective treatment for end-stage liver disease. As a traditional marginal donor liver, the application of SLT in pediatric patients is successful.However, its application in adult liver transplantation, especially in HCC patients, remains controversial.

This retrospective study analyze outcomes among adults who underwent SLT and whole liver transplantation (WLT) at two centers from January 2018 to August 2022. A 1:1 propensity score matching (PSM) analysis was performed based on important donor and recipient variables. Baseline characteristics and postoperative outcomes of the above recipients were analyzed and compared. Statistical significance was determined using a two-sided p-value threshold of less than 0.05.

Detailed Description

The primary objective of this study was to assess the safety and feasibility of split liver transplantation(SLT) for adult hepatocellular carcinoma (HCC) patients, while comparing the prognostic disparities between adult SLT and WLT also .

Liver transplantation (LT) is an effective treatment for end-stage liver disease. As a traditional marginal donor liver, the application of SLT in pediatric patients is successful.However, its application in adult liver transplantation, especially in HCC patients, remains controversial.

This retrospective study analyze outcomes among adults who underwent SLT and whole liver transplantation (WLT) at two centers from January 2018 to August 2022. A 1:1 propensity score matching (PSM) analysis was performed based on important donor and recipient variables. Baseline characteristics and postoperative outcomes of the above recipients were analyzed and compared. Statistical significance was determined using a two-sided p-value threshold of less than 0.05.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1
Inclusion Criteria
  1. ≥ 18 years old
  2. Received a liver transplantation between 2018 and 2022 (3) Liver transplantation was performed by SLT or WLT
Exclusion Criteria
  1. Re-LT
  2. Multiorgan transplantation
  3. Survival≤one week after LT
  4. Incomplete data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative complications were evaluated by postoperative imaging reports and serological indicatorsJan.1 2018-Dec.31 2022

Including rejection, emerging metabolic diseases, infections

The survival rate of each group was evaluated by follow-up survey and K-M curveJan.1 2018-Dec.31 2022

Including overall survival rate and/or tumor free survival rate

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xiao Xu

🇨🇳

Hangzhou, China

© Copyright 2025. All Rights Reserved by MedPath